These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22290017)

  • 41. Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease.
    Ciftçi C; Melil S; Cebi Y; Ersöz M; Cağatay P; Kiliçgedik M; Duman BS
    Lipids Health Dis; 2008 Feb; 7():5. PubMed ID: 18298848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endothelial nitric oxide synthase gene single nucleotide polymorphisms and the risk of hypertension: A meta-analysis involving 63,258 subjects.
    Xie X; Shi X; Xun X; Rao L
    Clin Exp Hypertens; 2017; 39(2):175-182. PubMed ID: 28287883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study.
    Liu Y; Burdon KP; Langefeld CD; Beck SR; Wagenknecht LE; Rich SS; Bowden DW; Freedman BI
    J Am Soc Nephrol; 2005 Apr; 16(4):1085-90. PubMed ID: 15743995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of endothelial nitric oxide synthase gene polymorphisms with early-onset ischemic stroke in South Indians.
    Majumdar V; Nagaraja D; Karthik N; Christopher R
    J Atheroscler Thromb; 2010 Feb; 17(1):45-53. PubMed ID: 20037257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Association of polymorphism 4a/4b and 4b/4b in endothelial nitric oxide synthase gene and markers of endothelial dysfunction in patients with chronic heart failure].
    Polunina EA; Voronina LP; Sevostyanova IV; Polunina OS; Tarasochkina DS
    Kardiologiia; 2018 SApr; (S4):4-9. PubMed ID: 29782277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. eNOS haplotypes associated with gestational hypertension or preeclampsia.
    Sandrim VC; Palei AC; Cavalli RC; Araújo FM; Ramos ES; Duarte G; Tanus-Santos JE
    Pharmacogenomics; 2008 Oct; 9(10):1467-73. PubMed ID: 18855535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of eNOS 27-bp VNTR (4b/a) gene polymorphism with the risk of Systemic Lupus Erythematosus in south Indian subjects.
    Katkam SK; Indumathi B; Tasneem FSD; Rajasekhar L; Kutala VK
    Gene; 2018 Jun; 658():105-112. PubMed ID: 29524578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association study of the endothelial nitric oxide synthase gene polymorphisms with essential hypertension in northern Han Chinese.
    Zhao Q; Su SY; Chen SF; Li B; Gu DF
    Chin Med J (Engl); 2006 Jul; 119(13):1065-71. PubMed ID: 16834924
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia.
    Sandrim VC; Palei AC; Sertorio JT; Cavalli RC; Duarte G; Tanus-Santos JE
    Mol Hum Reprod; 2010 Jul; 16(7):506-10. PubMed ID: 20457799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The 4a/4a genotype of the VNTR polymorphism for endothelial nitric oxide synthase (eNOS) gene predicts risk for proliferative diabetic retinopathy in Slovenian patients (Caucasians) with type 2 diabetes mellitus.
    Cilenšek I; Mankoč S; Globočnik Petrovič M; Petrovič D
    Mol Biol Rep; 2012 Jun; 39(6):7061-7. PubMed ID: 22311033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels.
    Imamura A; Takahashi R; Murakami R; Kataoka H; Cheng XW; Numaguchi Y; Murohara T; Okumura K
    Eur J Endocrinol; 2008 Feb; 158(2):189-95. PubMed ID: 18230825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic variants of eNOS gene may modify the susceptibility to idiopathic male infertility.
    Ying HQ; Pu XY; Liu SR; A ZC
    Biomarkers; 2013 Aug; 18(5):412-7. PubMed ID: 23756085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of beta-2 Thr164Ile and combined beta-adrenergic receptor polymorphisms on prognosis in a cohort of heart failure outpatients.
    Biolo A; Salvaro R; Clausell N; Silvello D; Santos KG; Rohde LE
    Braz J Med Biol Res; 2010 Jun; 43(6):565-71. PubMed ID: 20521014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of endothelial nitric oxide synthase (eNOS) T-786C, G894T, and 4a/b gene polymorphisms in the risk of idiopathic male infertility.
    Safarinejad MR; Shafiei N; Safarinejad S
    Mol Reprod Dev; 2010 Aug; 77(8):720-7. PubMed ID: 20586099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Promoter polymorphism T-786C, 894G→T at exon 7 of endothelial nitric oxide synthase gene are associated with risk of osteoporosis in Sichuan region male residents.
    Gu Z; Zhang Y; Qiu G
    Int J Clin Exp Pathol; 2015; 8(11):15270-4. PubMed ID: 26823879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects.
    Casas JP; Bautista LE; Humphries SE; Hingorani AD
    Circulation; 2004 Mar; 109(11):1359-65. PubMed ID: 15007011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endothelial nitric oxide synthase haplotypes associated with hypertension do not predispose to cardiac hypertrophy.
    Vasconcellos V; Lacchini R; Jacob-Ferreira AL; Sales ML; Ferreira-Sae MC; Schreiber R; Nadruz W; Tanus-Santos JE
    DNA Cell Biol; 2010 Apr; 29(4):171-6. PubMed ID: 20070154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationships between endothelial nitric oxide synthase gene polymorphisms and osteoporosis in postmenopausal women.
    Liu SZ; Yan H; Hou WK; Xu P; Tian J; Tian LF; Zhu BF; Ma J; Lu SM
    J Zhejiang Univ Sci B; 2009 Aug; 10(8):609-18. PubMed ID: 19650200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial nitric oxide synthase gene polymorphism and type 2 diabetic retinopathy among Asian Indians.
    Cheema BS; kohli HS; Sharma R; Bhansali A; Khullar M
    Acta Diabetol; 2012 Dec; 49(6):481-8. PubMed ID: 23085930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.
    Casadei Gardini A; Marisi G; Faloppi L; Scarpi E; Foschi FG; Iavarone M; Lauletta G; Corbelli J; Valgiusti M; Facchetti F; Della Corte C; Neri LM; Tamberi S; Cascinu S; Scartozzi M; Amadori D; Nanni O; Tenti E; Ulivi P; Frassineti GL
    Oncotarget; 2016 May; 7(19):27988-99. PubMed ID: 27058899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.